Differential immunoglobulin and complement levels in leprosy prior to development of reversal reaction and erythema nodosum leprosum-Reference-Cited by-同舟云学术

Differential immunoglobulin and complement levels in leprosy prior to development of reversal reaction and erythema nodosum leprosum

Published:2019-01-28 Issue:1 Volume:13 Page:e0007089
ISSN:1935-2735
Container-title:PLOS Neglected Tropical Diseases
language:en
Short-container-title:PLoS Negl Trop Dis

Author:

Amorim Francianne M.,Nobre Maurício L.,Nascimento Larissa S.,Miranda Alesson M.,Monteiro Glória R. G.,Freire-Neto Francisco P.,Queiroz Maria do Carmo Palmeira,Queiroz José W.,Duthie Malcolm S.,Costa Marcos R.,Reed Steven G.,Johnson Warren D.,Dupnik Kathryn M.^ORCID,Jeronimo Selma M. B.

Funder

Brazil National Institute of Science and Technology - Tropical Diseases

Heiser Foundation for Leprosy Research

Burroughs Wellcome Fund / American Society of Tropical Medicine and Hygiene

Publisher

Public Library of Science (PLoS)

Subject

Infectious Diseases,Public Health, Environmental and Occupational Health

Reference42 articles.

1. Chemotherapy of Leprosy for Control Programmes,1982

2. CD163 favors Mycobacterium leprae survival and persistence by promoting anti-inflammatory pathways in lepromatous macrophages;DF Moura;Eur J Immunol,2012

3. Comparative genomic and phylogeographic analysis of Mycobacterium leprae;M Monot;Nat Genet,2009